- Patent Title: Monoclonal antibodies against amyloid beta protein and uses thereof
-
Application No.: US15662224Application Date: 2017-07-27
-
Publication No.: US10323084B2Publication Date: 2019-06-18
- Inventor: Heinz Hillen , Stefan Barghorn , Boris Labkovsky , Ulrich Ebert , Andreas Striebinger , Patrick Keller
- Applicant: ABBVIE INC. , ABBVIE DEUTSCHLAND GMBH & CO KG
- Applicant Address: US IL North Chicago DE Wiesbaden
- Assignee: ABBVIE INC.,ABBVIE DEUTSCHLAND GMBH & CO. KG
- Current Assignee: ABBVIE INC.,ABBVIE DEUTSCHLAND GMBH & CO. KG
- Current Assignee Address: US IL North Chicago DE Wiesbaden
- Agency: Morrison & Foerster LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18 ; G01N33/68 ; G01N33/577 ; A61K39/00
Abstract:
The subject invention relates to monoclonal antibodies (e.g., 8F5 and 8C5) that may be used, for example, in the prevention, treatment and diagnosis of Alzheimer's Disease or other neurodegenerative disorders.
Public/Granted literature
- US20180066044A1 MONOCLONAL ANTIBODIES AGAINST AMYLOID BETA PROTEIN AND USES THEREOF Public/Granted day:2018-03-08
Information query
